Gates Foundation Funds Studies Into CRISPR/Cas9 Gene Editing for SCD
News
Intellia Therapeutics has received a grant from the Bill & Melinda Gates Foundation to develop sickle cell disease (SCD) treatments using the CRISPR/Cas9 genome editing technology, the company announced. ... Read more